Cochrane · systematic review · CD012328

Colonoscopy‐guided therapy for the prevention of post‐operative recurrence of Crohn’s disease

Candia, R, Bravo-Soto, GA, Monrroy, H, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
8
No studies
2
Included studies
NR
No studies 2 · 16.7%Ungraded 2 · 16.7%Very low 6 · 50%Low 2 · 16.7%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Intensification of prophylactic therapy guided by colonoscopy compared to intensification guided by clinical recurrence for the prevention of postoperative recurrence of Crohn’s disease

Population: adult participants (> 16 years of age) undergoing intestinal resection due to Crohn's disease
6 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical recurrence (
Intensification of prophylactic therapy guided by colonoscopy vs intensification guided by clinical recurrence
RR 0.82 [0.56, 1.18]1 study · 174 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Endoscopic recurrence (
Intensification of prophylactic therapy guided by colonoscopy vs intensification guided by clinical recurrence
RR 0.73 [0.56, 0.95]1 study · 174 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Surgical recurrence (
Intensification of prophylactic therapy guided by colonoscopy vs intensification guided by clinical recurrence
no estimate extracted504 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Mortality (
Intensification of prophylactic therapy guided by colonoscopy vs intensification guided by clinical recurrence
no estimate extracted1 study · 174 participantsUngraded
Quality of life
Intensification of prophylactic therapy guided by colonoscopy vs intensification guided by clinical recurrence
no estimate extractedNRNo studies
Adverse effects (
Intensification of prophylactic therapy guided by colonoscopy vs intensification guided by clinical recurrence
RR 0.78 [0.49, 1.25]1 study · 174 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency

Initiation of prophylactic therapy guided by colonoscopy compared to initiation of prophylactic therapy immediately after surgery for the prevention of postoperative recurrence of Crohn’s disease

Population: Adult participants (> 16 years of age) undergoing intestinal resection due to Crohn's disease.
6 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical recurrence (until week 102)
Initiation of prophylactic therapy guided by colonoscopy vs initiation of prophylactic therapy immediately after surgery
RR 1.16 [0.73, 1.84]1 study · 63 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Endoscopic recurrence (at week 102)
Initiation of prophylactic therapy guided by colonoscopy vs initiation of prophylactic therapy immediately after surgery
RR 1.16 [0.73, 1.84]1 study · 63 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Surgical recurrence (
Initiation of prophylactic therapy guided by colonoscopy vs initiation of prophylactic therapy immediately after surgery
RR 0.79 [0.38, 1.62]133 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Mortality (
Initiation of prophylactic therapy guided by colonoscopy vs initiation of prophylactic therapy immediately after surgery
no estimate extracted1 study · 63 participantsUngraded
Quality of life
Initiation of prophylactic therapy guided by colonoscopy vs initiation of prophylactic therapy immediately after surgery
no estimate extractedNRNo studies
Adverse effects (
Initiation of prophylactic therapy guided by colonoscopy vs initiation of prophylactic therapy immediately after surgery
RR 0.58 [0.42, 0.82]1 study · 63 participantsVery low
Downgraded: risk of bias, imprecision, indirectness